Treatment Advances in Locoregionally Advanced and Stage IVB/Recurrent Cervical Cancer: Can We Agree That More Is Not Always Better?

被引：7
|
作者：
Moore, Kathleen N. [1 ]
Rowland, Michelle R. [1 ]
机构：
[1] Univ Oklahoma, Stephenson Oklahoma Canc Ctr, Oklahoma City, OK USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 19期
关键词：
PELVIC RADIATION-THERAPY; PARAAORTIC LYMPH-NODES; PHASE-III TRIAL; CISPLATIN CHEMOTHERAPY; CONCURRENT CHEMOTHERAPY; PLUS CISPLATIN; ONCOLOGY-GROUP; CONCOMITANT PACLITAXEL; RANDOMIZED-TRIAL; IVA CARCINOMA;
D O I：
10.1200/JCO.2015.61.0998
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2125 / U142
页数：5
相关论文
共 15 条
  • [1] Advances in the treatment of locoregionally recurrent cervical cancer
    Hockel, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 991 - 991
  • [2] Topotecan with in combination cisplatin for the treatment of stage IVB, recurrent, or persistent cervical cancer
    Brave, Michael
    Dagher, Ramzi
    Farrell, Ann
    Abraham, Sophia
    Ramchandani, Roshni
    Gobburu, Jogarao
    Booth, Brian
    Jiang, Xiaoping
    Sridhara, Rajeshwari
    Justice, Robert
    Pazdur, Richard
    ONCOLOGY-NEW YORK, 2006, 20 (11): : 1401 - +
  • [3] Adjuvant treatment in early stage cervical cancer-does more equal better?
    Madariaga, Ainhoa
    Kasherman, Lawrence
    Han, Kathy
    Lheureux, Stephanie
    Oza, Amit M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (09) : 1467 - 1468
  • [4] Topotecan with in combination cisplatin for the treatment of stage IVB, recurrent, or persistent cervical cancer - The Brave/Dagher/Farrell et al article reviewed
    Fu, Siqing
    ONCOLOGY-NEW YORK, 2006, 20 (11): : 1410 - 1411
  • [5] Topotecan with in combination cisplatin for the treatment of stage IVB, recurrent, or persistent cervical cancer - The Brave et al article reviewed: Advocate's perspective
    Kaye, Alan M.
    ONCOLOGY-NEW YORK, 2006, 20 (11): : 1416 - 1416
  • [6] Better late than never: Brachytherapy is more important than timing in treatment of locally advanced cervical cancer
    Korenaga, Travis-Riley K.
    Yoshida, Emi J.
    Pierson, Will
    Chang, Jenny
    Ziogas, Argyrios
    Swanson, Megan L.
    Chapman, Jocelyn S.
    Sinha, Sumi
    Chen, Lee-may
    GYNECOLOGIC ONCOLOGY, 2022, 164 (02) : 348 - 356
  • [7] MESTASTATIC PARAAORTIC LYMPH NODES IN LOCALLY ADVANCED CERVICAL CANCER: DO WE NEED TO BE MORE AGRESSIVE IN THE TREATMENT?
    Benito, V.
    Lubrano, A.
    Carballo, S.
    Esparza, M.
    Arencibia, O.
    Medina, N.
    Andujar, M.
    Federico, M.
    Mori, M.
    Molano, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 705 - 705
  • [8] MESTASTATIC PARAAORTIC LYMPH NODES IN LOCALLY ADVANCED CERVICAL CANCER: DO WE NEED TO BE MORE AGRESSIVE IN THE TREATMENT?
    Benito, V.
    Lubrano, A.
    Carballo, S.
    Esparza, M.
    Arencibia, O.
    Medina, N.
    Andujar, M.
    Federico, M.
    Mori, M.
    Molano, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 126 - 126
  • [9] Two-stage cervical cancer testing: More women can be screened, and fewer undergo unnecessary treatment
    Mahler, K
    INTERNATIONAL FAMILY PLANNING PERSPECTIVES, 2001, 27 (01): : 47 - 48
  • [10] A RANDOMIZED CONTROLLED PHASE II CLINICAL TRIAL OF APATINIB PLUS CHEMOTHERAPY IN THE FIRST-LINE(1L) TREATMENT OF IVB STAGE, RECURRENT OR PERSISTENT CERVICAL CANCER
    Zhou, Y.
    Jiang, Y.
    Zheng, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A139 - A139
12